We will improve the health and well being of people and animals through being a part of an independent, innovative, research and development driven company. Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Click here for our Global Vision.
Learn more about Pharmaphorum and Boehringer Ingelheim's White paper
Facts about us
We are one of the top 20 leading pharmaceutical companies in the world.
In 2010, worldwide, we had sales of €12.6 billion; while spending 24% of net sales in our largest business segment Prescription Medicines on research and development.
Our key areas of interest are: respiratory disease, cardiovascular disease, HIV, Parkinson's disease, thromboembolic disease and cerebrovascular disease.